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Abstract A consistent clinical feature of amyotrophic
lateral sclerosis (ALS) is the sparing of eye movements
and the function of external sphincters, with correspond-
ing preservation of motor neurons in the brainstem
oculomotor nuclei, and of Onuf’s nucleus in the sacral
spinal cord. Studying the differences in properties of
neurons that are vulnerable and resistant to the disease
process in ALS may provide insights into the mechanisms
of neuronal degeneration, and identify targets for thera-
peutic manipulation. We used microarray analysis to
determine the differences in gene expression between
oculomotor and spinal motor neurons, isolated by laser
capture microdissection from the midbrain and spinal cord
of neurologically normal human controls. We compared
these to transcriptional profiles of oculomotor nuclei and
spinal cord from rat and mouse, obtained from the GEO
omnibus database. We show that oculomotor neurons
have a distinct transcriptional profile, with significant
differential expression of 1,757 named genes (q \ 0.001).
Differentially expressed genes are enriched for the functional
categories of synaptic transmission, ubiquitin-dependent
proteolysis, mitochondrial function, transcriptional regu-
lation, immune system functions, and the extracellular
matrix. Marked differences are seen, across the three
species, in genes with a function in synaptic transmission,
including several glutamate and GABA receptor subunits.
Using patch clamp recording in acute spinal and brainstem
slices, we show that resistant oculomotor neurons show a
reduced AMPA-mediated inward calcium current, and a
higher GABA-mediated chloride current, than vulnerable
spinal motor neurons. The findings suggest that reduced
susceptibility to excitotoxicity, mediated in part through
enhanced GABAergic transmission, is an important
determinant of the relative resistance of oculomotor neu-
rons to degeneration in ALS.
Introduction
Amyotrophic lateral sclerosis (ALS) is an adult-onset
neurodegenerative disorder, in which there is selective loss
of motor neurons in the cerebral cortex, brainstem and
spinal cord. Symptoms often begin focally but with pro-
gression of disease, there is spread of weakness to the limb,
bulbar and respiratory muscles. Mean survival from onset
is 3 years. On pathological examination, there is loss of
lower motor neurons in the ventral horn of the spinal cord,
with astrocytic gliosis, and the presence of ubiquitinated
inclusions in surviving motor neurons. An upper motor
Electronic supplementary material The online version of this
article (doi:10.1007/s00401-012-1058-5) contains supplementary
material, which is available to authorized users.
A. Brockington  K. Ning  P. R. Heath  E. Wood 
J. Kirby  P. J. Shaw (&)
Academic Neurology Unit, Sheffield Institute for Translational
Neuroscience (SITraN), University of Sheffield, 385A Glossop
Road, Sheffield S10 2HQ, UK
e-mail: pamela.shaw@sheffield.ac.uk
A. Brockington
e-mail: alicebrockington@yahoo.co.uk
S. B. Wharton  P. G. Ince
Academic Neuropathology Unit, Sheffield Institute
for Translational Neuroscience (SITraN), University
of Sheffield, 385A Glossop Road, Sheffield S10 2HQ, UK
N. Fusi  N. Lawrence
Computational Biology Unit, Sheffield Institute for Translational
Neuroscience (SITraN), University of Sheffield, 385A Glossop
Road, Sheffield S10 2HQ, UK
123
Acta Neuropathol (2013) 125:95–109
DOI 10.1007/s00401-012-1058-5
neuron axonopathy is demonstrated by myelin pallor and
gliosis of the corticospinal tracts, which may be accom-
panied by a reduction in cortical pyramidal neurons [17].
Approximately 5 % of ALS cases are familial, and 70 % of
these have mutations in C9ORF72, SOD1, TDP43 or FUS.
In the majority of ALS cases, the cause of motor neuron
degeneration is unknown, although a number of pathogenic
processes, including excitotoxicity, oxidative stress, pro-
tein aggregation, mitochondrial dysfunction, dysregulation
of the cytoskeleton and axonal transport, and inflammation
are considered to play important roles [9].
A consistent clinical feature of the disease is the sparing
of eye movements and the function of external sphincters,
so that patients retain continence. Pathological studies have
confirmed that there is relative sparing of the cranial motor
nuclei of the oculomotor, trochlear and abducens nerves,
and of Onuf’s nucleus in the sacral spinal cord, which
innervates the external sphincters of the pelvic floor [36].
Although neuronal numbers are relatively well-preserved
in these resistant motor nuclei, pathological changes
resembling those seen in anterior horn cells are present to a
lesser degree [40, 41]. The earliest and most severe chan-
ges in ALS affect motor neurons, but there is increasing
recognition of variable clinical and pathological involve-
ment outside the motor system. Fronto-temporal dementia
(FTD), or more subtle cognitive deficits may affect patients
with ALS [27], with ubiquitinated inclusions in the dentate
granule cells and neocortex [33]. Other long tracts,
including the dorsal column and spinocerebellar tracts [17]
show degenerative changes in some patients. Patients who
are treated with ventilation for a prolonged period after the
onset of respiratory failure may develop more widespread
CNS degeneration including, in some cases, loss of ocu-
lomotor neurons on neuropathological examination [13].
Thus ALS is a degenerative disease, in which motor
neurons are relatively selectively vulnerable, but other
neuronal subgroups are affected in some patients, particu-
larly after a prolonged disease course. Two groups of lower
motor neurons: the oculomotor nuclei, and the sacral
nucleus of Onuf, are relatively resistant to the disease
process. Rodents which overexpress mutant human SOD1
develop motor neuron degeneration, and in this animal
model of ALS, oculomotor nuclei are also relatively spared
[38]. Studying the differences in properties of neurons that
are vulnerable and those that are resistant to the disease
process in ALS may provide insights into the mechanisms
of neuronal degeneration, and identify targets for thera-
peutic manipulation.
The oculomotor nucleus innervates four of the six
extraocular muscles (EOMs), which display a distinct
phenotype, gene expression profile [49] and disease
responsiveness [47]. They have a unique composition of
six fibre types, distinct from other skeletal muscles, some
with very high mitochondrial content and marked fatigue
resistance. Such differences may be determined by their
distinct embryonic origin, or by demands imposed by the
relative complexity of oculomotor control systems, and the
specific discharge patterns of oculomotor neurons [46].
Motor unit discharge patterns are a key determinant of
skeletal muscle properties, and EOMs and oculomotor
neurons interact in a highly specific manner: explants of
neonatal extraocular muscle grown in co-culture with the
incorrect spinal motor neurons die faster than those grown
with oculomotor neurons [48]. The pattern of innervation
of EOMs is different from other skeletal muscles. Neuro-
muscular junctions are distributed throughout the fibre
length at a higher density [12], and show some structural
differences [23]. 20 % of EOM fibres are innervated by
multiple neuromuscular junctions [44]. Oculomotor motor
units are amongst the smallest seen in any skeletal muscle,
[47], with higher maximum motor neuron discharge rates.
Even in the primary position of gaze, 70 % of oculomotor
neurons are active, commonly discharging at 100 Hz [50].
This level of activity would be predicted to place a sig-
nificant metabolic demand on the neuron.
We have used microarray analysis to compare the gene
expression profiles of isolated motor neurons from the
ALS-resistant oculomotor nucleus and ALS-vulnerable
spinal cord in post-mortem tissue from four neurologically
normal control subjects. We show that motor neuron sub-
types with different susceptibility to the disease process in
ALS also have markedly different transcriptional profiles.
Oculomotor (OM) and lumbar spinal cord (LSC) motor
neurons show differential expression of genes with a
function in synaptic transmission, ubiquitin-dependent
proteolysis, mitochondrial function, transcriptional regula-
tion, immune system functions, and the extracellular
matrix. The most striking differences are seen in genes
with a function in synaptic transmission, in particular
GABA and glutamate receptor subunits. We have validated
these observed changes, using unpublished transcriptional
data from the oculomotor nucleus and spinal cord of two
other species, obtained from the public repository GEO
Omnibus. Furthermore, we demonstrate the functional
impact of altered expression of GABA and glutamate
receptors on whole-cell currents induced by agonists at
GABA and glutamate receptors.
Materials and methods
Case selection
Brain and spinal cord tissue from four neurologically
normal human control subjects (Table 1) was obtained
from the Sheffield Brain Tissue Bank. Tissue donated for
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research was obtained with informed consent from the next
of kin, and in accordance with the Human Tissue Authority
guidelines on tissue donation. Midbrain and lumbar spinal
cord sections were collected postmortem, processed
according to standard protocols [18], and stored at -80 C
until required. No abnormality of the midbrain or spinal
cord was found at postmortem on full neuropathological
examination.
Tissue preparation and laser capture microdissection
Frozen tissue sections were mounted in Cryo-M-Bed
embedding compound (Bright UK), and 10 lm sections cut
in a cryostat at -22 C. Frozen sections were thaw
mounted onto slides at room temperature, fixed in 70 %
ethanol, washed in DEPC-treated water, and stained for
1 min in a solution of 0.1 % w/v Toluidine Blue in 0.1 M
sodium phosphate. They were then washed and dehydrated
through graded ethanol concentrations (70, 90 and 100 %),
and xylene. OM and LSC motor neurons, identified by
staining, anatomical location, size and morphology, were
isolated on Capsure Macro LCM caps using the Arcturus
PixCell II laser capture microdissection system (Arcturus
Bioscience). Approximately 800 successful laser capture
firings were made from the spinal cord and 800 from the
OM nucleus of each case (supplementary figure 1). The
procedure of laser capture microdissection does not prevent
the collection of small amounts of adjacent neuropil and
glial cells, but significantly enriches the extracted RNA for
motor neuron-expressed transcripts.
RNA isolation and amplification, and Affymetrix
GeneChip processing
From each sample [50 ng RNA was extracted using the
PicoPureTM RNA isolation kit (Arcturus), and amplified
using a 2-cycle linear amplification process, with the
GeneChip two-cycle target labelling and control kit
(Affymetrix), and MEGAscript T7 kit (Ambion). The
linear amplification technique has been shown to generate
highly reproducible gene expression profiles from small
starting quantities of RNA [32]. This procedure produced
50–100 lg of biotin-labelled antisense RNA for each
sample. 15 lg amplified cRNA was fragmented by heating
to 94 C for 20 min, and spiked hybridization controls
were added. Each sample was hybridized to one GeneChip
Human Genome U133 Plus 2.0 Array (Affymetrix) and
scanned in the GeneChip Scanner 3000 to detect fluores-
cent hybridization signals. We carried out quality control
(QC) measures, according to Affymetrix protocols, to
ensure that RNA was of sufficient quality and was matched
between samples. CEL files generated by the Affymetrix
GeneChip Operating System were taken forward for
microarray data analysis.
Microarray data analysis
We wanted to detect differentially expressed transcripts
between the group of oculomotor samples and the group of
spinal cord samples. The bioconductor1 [10] package
PUMA [45] was used to carry out the normalization and
differential expression analysis. PUMA is a Bayesian
probabilistic model for probe-level analysis that takes into
account the probe-level measurement error while estimat-
ing the gene expression levels. This measurement error is
propagated downstream into the analysis, for instance
when detecting differentially expressed transcripts This has
been shown to increase the accuracy in detecting differ-
ential expression, making the model more resistant to
outliers even at small sample sizes [29]. The output of this
procedure is the posterior probability (PPLR value), esti-
mated using Bayesian inference, of a transcript’s
differential expression in the group of oculomotor samples
and the group of spinal cord samples. Since this compu-
tation is essentially a univariate test, care must be taken to
account for multiple hypotheses testing. For this reason, we
computed q values from the posterior probabilities as
suggested in [52]. Genes that were significantly (q value
less than 0.001) differentially expressed were assigned
Gene Ontology (Gene Ontology project; http://www.
geneontology.org/ [1]) and Kegg Pathway (Kyoto Ency-
clopaedia of Genes and Genomes; http://www.genome.jp/
kegg/ [20]) annotations, and gene ontology (GO) enrich-
ment analysis was performed using DAVID software
(NIAID/NIH; http://david.abcc.ncifcrf.gov/summary.jsp,
[6]).
Table 1 Characteristics of
cases
Case number Sex Age at death Cause of death Postmortem delay time (h)
1 M 64 Ischaemic heart disease 12
2 M 64 Empyema 30
3 F 59 Pneumonia 5
4 M 67 Hepatocellular carcinoma 63
1 Bioconductor is an open-source computational framework for the
analysis of high-throughput genomic data implemented in the R
programming language.
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Analysis of differential expression of oculomotor
nucleus and spinal cord tissue of rat and mouse
Two datasets were obtained from the Gene Expression
Omnibus public functional genomics data repository (http://
www.ncbi.nlm.nih.gov/geo/). Dataset GSE3305 analysed
total RNA extracted from OM nucleus and spinal cord of
rats at 6, 18 and 30 months of age, using TRIzol. Tissues
from four animals were combined in each RNA sample.
Biotinylated RNA samples were hybridized to rat RA230
Affymetrix microarray chips (n = 18). Dataset GSE3343
analysed RNA extracted from the oculomotor nucleus and
spinal cord of mice at 10 weeks of age, hybridized to mouse
430A Affymetrix microarray chips (n = 6). The data were
normalized, and probe-level analysis conducted using
MAS5 software, and made freely available to the scientific
community. For the purposes of the present study, as there
were relatively few significant differences in the gene
expression profile between the three rat age groups, the data
from 6, 18 and 30 months were combined. As the .CEL files
were unavailable in the repository for PUMA analysis,
differential expression between oculomotor and spinal tis-
sue was determined using an unpaired t test.
Quantitative PCR
RNA extracted from laser-captured OM and LSC motor
neurons as above, which was not required for hybridization
to microarray chips, was taken forward for use in quanti-
tative PCR to verify expression levels of GABRA1. cDNA
was synthesized using Superscript II reverse transcriptase,
according to manufacturer’s protocol (Invitrogen). QPCR
was performed using 12.5 ng cDNA, 19 SYBR Green
PCR master mix (Applied Biosystems), 900 nM forward
primer (CCTTCCAGACTTCTCATGGCTAAC) and
600 nM reverse primer (TAGCAGGAAGCAGACTAA-
TAAGAAATATTC), to a total volume of 20 ll. After an
initial denaturation at 95 C for 10 min, templates were
amplified by 40 cycles of 95 C for 15 s and 60 C for
1 min, on an MX3000P Real-Time PCR system (Strata-
gene). Gene expression values, calculated using the DDCt
calculation (ABI PRISM 7700 Sequence Detection System
protocol; Applied Biosystems), were normalized to b-actin
expression, and statistical analysis performed using an
unpaired t test.
Preparation of acute spinal cord and midbrain slices
for patch clamp recording
Adult male Sprague-Dawley rats were anaesthetized with
sodium pentobarbital (50 mg kg-1) and decapitated accord-
ing to the UK Animal (Scientific Procedures) Act 1986
guidelines. Brainstem was isolated, glued on its rostral end to
the stage of a vibroslicer, and sliced from the caudal end to the
midbrain region of OM nucleus, identified by anatomical
landmarks. Two or three 300-lm-thick transverse slices
through the OM nucleus were obtained per preparation. The
spinal cord was isolated, and 300 lm transverse sections
prepared from the lumbar limb expansion, using a McIlwain
tissue chopper. Slices were maintained in continuously bub-
bled (95 % O2/5 % CO2) bicarbonate buffered saline for at
least 1 h prior to recordings.
Electrophysiology
Whole-cell electrophysiological experiments were recorded
as previously described [39]. The location of electrode
placement for OM neuron recording is shown in supple-
mentary figure 2. The constituents of all buffers used are
detailed in the supplementary experimental procedures.
Voltage clamp recordings were performed using an Axon
Multi-Clamp 700B amplifier (Axon Instruments) using
unpolished borosilicate pipettes placed at the cell soma.
Pipettes had a resistance of 2–4 MX when filled with
intracellular solution. Pipettes filled with high concentra-
tions of Cl- for GABA-induced current recordings were
used to maintain the Cl- equilibrium potential close to
0 mV, thereby facilitating the observation of GABAR-
mediated whole-cell currents at resting potentials. Cs? in
the pipette solution would block K?-dependent membrane
conductance. Cells were accepted for study if a stable seal
formed with a whole-cell resistance of at least 120 MX and
a series resistance of\10 MX. Receptors were activated by
focal perfusion of agonists from a micropipette with its tip
located 30–50 lm from the cell. Three cells were used for
dose–response recordings for AMPA (5 lM to 5 mM) or
kainate (50 lM to 50 mM)-induced whole-cell currents in
OM and LSC motor neurons. Currents were recorded in
extracellular perfusion buffer with 20 mM extracellular
Na? at -60 mV. Na? was reduced from 125 mM in normal
extracellular solution to 20 mM to reduce the driving force
for agonist-evoked current. 100 lM AMPA and 1 mM
kainate, which were close to the EC50 from the dose–response
recordings, were used to measure Ca2? permeability of
AMPA receptors in six cells per agonist, in Na?-free
extracellular solutions containing 50 mM Ca2?. Three cells
were used for dose–response recording for GABA
(0.1–100 mM)-induced whole-cell currents in OM and LSC
motor neurons. 10 mM GABA, which was close to the EC50
of the dose–response recordings, was used for repeat
recording in six cells. All extracellular solutions were
supplemented with MK-801 (10 lM), tetrodotoxin
(1.0 lM), and Cd2? (100 lM) to block NMDA receptors,
voltage-gated Na? channels, and Ca2? channels, respec-
tively. Cells were held at a membrane potential of -60 mV.
All recordings were performed at room temperature 21 C.
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Current recordings were sampled onto an IBM-PC-com-
patible computer using pClamp10 software (Axon). Data
were filtered at 3 kHz and sampled at 20–40 kHz.
Results
Overall patterns of differential gene expression
A total of 1,521 unique named genes were upregulated in
OM neurons, and 236 in LSC motor neurons, at a signifi-
cance level of q \ 0.001, which was the threshold used for
downstream analysis (Table 2). OM and LSC motor neu-
rons cluster according to their gene expression profiles, as
shown in the covariance plot (Fig. 1).
Gene ontology analysis
Gene ontology (GO) analysis was performed to determine
the functional categories over-represented amongst signifi-
cantly differentially expressed genes. A significant
proportion of genes expressed at higher levels in OM neu-
rons belonged to the functional clusters of synaptic
transmission, ubiquitin-mediated protein degradation, and
mitochondrial oxidative phosphorylation (Fig. 2a;
Table 3). Genes involved in all stages of ubiquitin-mediated
proteolysis, and genes with mitochondrial functions,
including the respiratory chain complex were upregulated
in OM neurons (Supplementary tables 1 and 2). Three
KEGG pathways relevant to neurodegenerative diseases
(Huntington’s disease, Alzheimer’s disease and Parkinson’s
disease) were also enriched amongst genes upregulated in
OM neurons. Although ALS was not an enriched functional
category, there was upregulation in OM neurons of the
expression of a number of genes in which mutations are
known to cause motor neuron degeneration, including
C9ORF72 (FC 2.56, q = 4.0E-6), BSCL2 (FC 3.09,
q = 0.003), optineurin (FC 2.0, q = 0.001), spastin (FC
2.4, q = 2.95E-6), and VAPB (FC 1.8, q = 1.0E-5).
In LSC motor neurons, upregulated genes were enriched
for the functions of skeletal system development, anterior/
posterior pattern formation, immune system processes, the
extracellular matrix, cell adhesion, and transcription
(Fig. 2b; Table 3). Transcriptional regulators expressed at
a higher level in LSC motor neurons included 17 of the 39
homeobox (Hox) genes which operate distinct genetic
programs along the anterior/posterior axis (Supplementary
table 3), and MALAT1, a non-coding RNA recently
identified as a principle binding target of TDP43, and
thought to play a role in the recruitment of splicing factors
[55], which is 8.7-fold upregulated in LSC motor neurons
relative to OM neurons (q value \1.0E-17). Homeobox
genes engrailed 1 and 2, which are known molecular
markers of midbrain tissue [5] were upregulated in OM
neurons. Extracellular matrix components expressed at
higher levels in LSC motor neurons included seven dif-
ferent collagen subunits (Supplementary table 4).
The majority of gene ontology categories enriched in OM
and LSC-upregulated genes identify functions which are
known to play a role in the pathogenesis of ALS. It was not
possible within the scope of this study to explore the potential
role that each functional category may play in the relative
resistance of OM neurons to the degenerative process. We
focussed on the differences observed in the most highly
enriched functional category of synaptic transmission.
Differential expression of genes with a function
in synaptic transmission
Glutamate-mediated neurotransmission
A number of glutamate receptor subunits were upregulated
in OM neurons (Table 4). The AMPA glutamate receptor
subtype consists of four subunits, GluR1–GluR4, and the
presence of the GluR2 subunit determines the calcium
permeability of the receptor. In the absence of GluR2, the
AMPA receptor–ion channel complex becomes permeable
to calcium. In this study, we showed upregulation of the
GluR2 subunit in resistant OM neurons, relative to the
vulnerable lumbar motor neuron population. The GluR1
subunit was also expressed at higher levels, as were the
synaptic scaffolding proteins, GRIP1 and 2, which interact
with GluR2 and GluR3 to stabilize these receptor subunits
at the synaptic membrane [7]. There was no differential
expression of NMDA receptors.
GABA-mediated neurotransmission
GABA is the most widely distributed inhibitory neuro-
transmitter in the mammalian CNS. It signals through
Table 2 Numbers of
differentially expressed probe
sets and PPLR values at
different thresholds of q
q value threshold Upregulated in oculomotor neurons Upregulated in spinal motor neurons
No. of probe sets PPLR values No. of probe sets PPLR values
1.0e-5 957 \7.66e-5 209 \1.17e-4
1.0e-4 1,417 \0.00060 265 \0.000899
1.0e-3 2,196 \0.0059 340 \0.011
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Fig. 1 Covariance matrix for
the gene expression dataset,
evaluated using only the top 100
differentially expressed genes.
The samples on both axes are
ordered according to the tissue
type. The two visible blocks
correspond to the two groups,
indicating that the most
differentially expressed genes
are able to capture the
difference between oculomotor
and spinal cord samples. Each
square in the plot shows the
correlation between each pair of
samples. Warm colours
correspond to a high positive
correlation, while cold colours
correspond to a high negative
correlation
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Fig. 2 Numbers of significantly differentially expressed genes
assigned to enriched gene ontology terms. The 20 most enriched
KEGG pathways and GO terms in the categories of biological process
and cell component are shown. Redundant terms were removed for
clarity. a Genes upregulated in oculomotor neurons (q value for
enrichment \0.05). Group 1 synaptic function, Group 2 ubiquitin-
mediated proteolysis, Group 3 oxidative phosphorylation and mito-
chondrial function, Group 4 other. b Genes upregulated in spinal
motor neurons (q value for enrichment \0.005). Group 1 skeletal
development, Group 2 embryonic pattern formation, Group
3 immune system processes, Group 4 the extracellular matrix, Group
5 cell adhesion, Group 6 regulation of transcription, Group 7 other
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Table 3 Gene ontology enrichment analysis
Gene ontology term Count P value q value Fold
enriched
GO terms enriched in genes upregulated in oculomotor neurons
1. Synaptic function GO:0045202—synapse 79 2.60E-14 1.32E-10 2.50
GO:0008021—synaptic vesicle 25 1.91E-08 2.42E-05 3.70
GO:0007268—synaptic transmission 57 1.98E-07 0.00012 2.07
GO:0045211—postsynaptic membrane 27 0.000125 0.015 2.25
GO:0019717—synaptosome 20 0.00013 0.015 2.65
GO:0001505—regulation of neurotransmitter levels 18 9.25E-05 0.012 2.90
2. Ubiquitin-dependent
proteolysis
GO:0019941—modification-dependent protein catabolic process 94 4.57E-08 3.86E-05 1.77
hsa04120: ubiquitin-mediated proteolysis 25 0.00048 0.043 2.13
3. Mitochondrial function hsa00190: oxidative phosphorylation 31 2.85E-07 0.00014 2.78
GO:0005746—mitochondrial respiratory chain 18 2.94E-05 0.0055 3.16
GO:0005739—mitochondrion 135 4.15E-05 0.0075 1.40
GO:0031966—mitochondrial membrane 59 8.51E-05 0.012 1.68
GO:0022900—electron transport chain 25 9.91E-05 0.013 2.37
GO:0030964—NADH dehydrogenase complex 13 0.00020 0.020 3.48
4. Other hsa05012: Parkinson’s disease 30 6.85E-07 0.00031 2.73
GO:0031982—vesicle 97 1.39E-06 0.00050 1.63
GO:0005794—Golgi apparatus 117 4.68E-06 0.0013 1.51
GO:0043005—neuron projection 57 5.05E-06 0.0013 1.87
hsa05010: Alzheimer’s disease 33 5.14E-06 0.0013 2.36
hsa05016: Huntington’s disease 34 1.68E-05 0.0034 2.20
GO terms enriched in genes upregulated in spinal motor neurons
1. Skeletal system GO:0001501—skeletal system development 33 1.09E-16 3.17E-13 6.30
GO:0048704—embryonic skeletal system morphogenesis 12 1.65E-09 6.01E-07 12.83
GO:0001649—osteoblast differentiation 8 4.69E-06 0.00031 11.61
2. Ant/post specification GO:0009952—anterior/posterior pattern formation 21 1.14E-13 1.66E-10 9.14
GO:0007389—pattern specification process 26 1.62E-12 1.57E-09 5.93
3. Immune response GO:0006955—immune response 36 1.97E-09 6.37E-07 3.18
GO:0046649—lymphocyte activation 18 2.76E-08 7.31E-06 5.51
GO:0042110—T cell activation 14 1.39E-07 2.18E-05 6.77
GO:0009611—response to wounding 28 1.52E-07 2.21E-05 3.22
GO:0002684—positive regulation of immune system process 16 8.57E-06 0.000509 4.10
GO:0002520—immune system development 18 2.88E-06 0.000215 3.97
GO:0006954—inflammatory response 18 2.46E-05 0.00116 3.37
4. Extracellular matrix GO:0031012—extracellular matrix 22 2.42E-07 3.36E-05 3.86
GO:0005581—collagen 7 2.00E-05 0.000971 12.12
5. Cell adhesion GO:0007155—cell adhesion 31 1.21E-06 0.000113 2.70
GO:0010810—regulation of cell-substrate adhesion 8 8.79E-06 0.000512 10.60
6. Transcription GO:0045893—positive regulation of transcription, DNA-
dependent
23 1.15E-05 0.000598 2.94
GO:0051254—positive regulation of RNA metabolic process 23 1.32E-05 0.000663 2.91
7. Other GO:0001568—blood vessel development 17 2.68E-06 0.000205 4.23
GO:0042127—regulation of cell proliferation 31 1.26E-05 0.000644 2.40
The 20 most enriched KEGG pathways and gene ontology terms in the categories of biological process and cell component are shown for each
motor neuron subtype. Redundant terms were removed for clarity. P value and q value apply to the fold enrichment
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GABAA ligand-gated chloride channels, composed of dif-
ferent combinations of 16 subunits, and GABAB
metabotropic receptors, which are heterodimers of subunits
1 and 2. In OM neurons, there was upregulation relative to
LSC motor neurons, of six GABAA receptor subunits and
of GABAB receptor subunit 2 (Table 5). The differential
expression of GABRA1 was confirmed using quantitative
PCR (Fig. 3). Relative concentration of GABRA1 was
16-fold higher in OM neurons compared to LSC motor
neurons, when determined by QPCR.
Verification of microarray findings by QPCR
and in other species
Limited motor neuron numbers in the oculomotor nucleus
precluded the verification of differential expression by
QPCR in a large panel of genes. We therefore aimed to
confirm the changes found in human tissue, using micro-
array datasets from two other species—rat and mouse,
which were obtained from a public repository. These
studies were performed on whole oculomotor nucleus and
whole spinal cord, and the gene expression profiles
obtained are therefore from a more heterogeneous cell
population than that of our human study, which was highly
enriched for motor neurons, due to the laser capture pro-
cess. Nevertheless, the differential gene expression profiles
obtained from mouse and rat oculomotor nucleus versus
spinal cord, and those from human OM neurons versus
LSC motor neurons were highly correlated. On gene
ontology analysis, only 2 of the top 20 GO terms enriched
amongst genes upregulated in OM neurons and LSC motor
neurons, respectively, were unique to the human study, the
others all being significantly enriched in the mouse and/or
rat study. In both other species, functional categories
Table 4 Upregulated glutamate receptor subunits and transporters in human oculomotor neurons
Gene name Symbol Probe id Fold change PPLR value q value
Glutamate receptor, ionotropic, AMPA 1 GLUR1 209793_at 4.82 3.49E-15 0
211520_at 3.20 5.60E-06 6.59E-07
Glutamate receptor, ionotropic, AMPA 2 GLUR2 205358_at 2.31 1.14E-05 1.36E-06
236538_at 3.31 0.002008 0.00031
Glutamate receptor, ionotropic, kainate 2 GRIK2 213845_at 5.34 5.09E-07 4.74E-08
Glutamate receptor, metabotropic 3 GRM3 205814_at 2.00 3.58E-08 3.42E-09
Glutamate receptor, metabotropic 7 GRM7 207548_at 2.50 2.30E-06 2.72E-07
Glutamate receptor interacting protein 1 GRIP1 235957_at 2.57 6.37E-06 7.33E-07
Glutamate receptor interacting protein 2 GRIP2 216481_at 3.80 3.19E-09 2.23E-10
Table 5 Upregulated GABA receptor subunits and genes in human oculomotor neurons
Gene name Symbol Probe id Fold change PPLR value q value
Gamma-aminobutyric acid (GABA) A receptor, alpha 1 GABRA1 244118_at 7.56 1.16E-07 1.08E-08
Gamma-aminobutyric acid (GABA) A receptor, beta 1 GABRB1 207010_at 5.21 5.35E-08 4.57E-09
Gamma-aminobutyric acid (GABA) A receptor, beta 2 GABRB2 155712 _at 8.76 3.78E-20 0
242344_at 9.21 2.61E-05 3.21E-06
Gamma-aminobutyric acid (GABA) A receptor, epsilon GABRE 204537_at 8.18 1.54E-08 1.62E-09
Gamma-aminobutyric acid (GABA) A receptor, gamma 1 GABRG1 241805_at 2.79 7.27E-05 9.25E-06
Gamma-aminobutyric acid (GABA) receptor, theta GABRQ 238123_at 26.3 1.13E-08 9.84E-10
Gamma-aminobutyric acid (GABA) B receptor, 2 GABBR2 209990_at 3.10 4.93E-09 4.30E-10
211679_at 2.33 4.83E-06 5.75E-07
Fig. 3 Concentration of GABRA1 relative to b-actin in laser-
captured motor oculomotor and spinal motor neurons determined by
QPCR (2 cases, n = 6 replicates). Error bars represent SEM
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relating to synaptic transmission were the most highly
enriched in differentially expressed genes (Supplementary
table 5). Homologues of 12 of the 16 GABA and glutamate
receptor subunits that were significantly differentially
expressed between human OM neurons and LSC motor
neurons were also significantly differentially expressed
between oculomotor nucleus and spinal cord in mouse and/
or rat tissue (Table 6).
Glutamate and GABA receptor-mediated currents
in lumbar spinal cord and oculomotor neurons
in slice preparations from rat
The functional significance of the observed changes in
glutamate and GABA receptor subunits was determined
using patch clamp recording of whole-cell currents in slice
preparations of the rat lumbar spinal cord and midbrain. To
assess AMPA receptor-mediated whole-cell currents, three
cells were used for dose–response recordings for AMPA-
and kainate-induced whole-cell currents in OM and LSC
motor neurons. 100 lM AMPA and 1 mM kainate were used
to measure Ca2? permeability of AMPA receptors in six cells
per agonist. Both AMPA- and kainate-induced currents were
significantly larger in LSC motor neurons than in OM neu-
rons. AMPA-induced currents were 614.00 ± 102.21 pA in
LSC motor neurons and 340.67 ± 58.80 pA in OM neurons.
Kainate-induced currents were 629.50 ± 334.57 in LSC
motor neurons and 300.50 ± 34.22 in OM neurons (Fig. 4).
To assess GABA receptor-mediated whole-cell currents,
three cells were used for dose–response recording for
GABA. 10 mM GABA was used for repeat recording in six
cells. Amplitudes of whole-cell currents evoked by 10 mM
GABA were significantly smaller in LSC motor neurons than
in OM neurons. GABA-induced currents were 160.33 ±
62.43 pA in LSC motor neurons and 250.33 ± 58.03 pA in
OM neurons (Fig. 5).
Discussion
We have identified marked differences in the transcrip-
tional profiles of human spinal motor neurons, which are
Table 6 Significantly upregulated glutamate and GABA receptor subunits and genes in mouse and rat oculomotor nucleus
Gene name Symbol Mouse Rat
Probe id Fold
change
P value Probe id Fold
change
P value
Glutamate receptor, ionotropic, AMPA 1 GLUR1 1435239_at 2.49 0.0024 1371013_at 2.05 4.79E-06
1448972_at 1.83 0.0379
Glutamate receptor, ionotropic, AMPA 2 GLUR2 1387171_at 2.19 4.86E-09
1368401_at 2.02 4.23E-08
Glutamate receptor, metabotropic 7 GRM7 1369781_at 1.29 0.0011
Glutamate receptor interacting protein 1 GRIP1 1376988_at 1.48 0.0101
Glutamate receptor interacting protein 2 GRIP2 1387954_at 1.29 0.0011
1388016_at 4.95 2.38E-06
Gamma-aminobutyric acid (GABA) A receptor, alpha 1 GABRA1 1421281_at 8.24 1.98E-04
1436889_at 5.62 1.85E-05
Gamma-aminobutyric acid (GABA) A receptor, beta 1 GABRB1 1369904_at 2.30 3.82E-04
1369371_at 1.96 1.42E-08
1388030_at 1.71 5.67E-04
1388039_at 1.42 9.54E-07
1375720_at 1.39 6.49E-07
Gamma-aminobutyric acid (GABA) A receptor, beta 2 GABRB2 1450319_at 2.39 0.0059 1369818_at 2.51 1.93E-06
1387383_at 1.64 3.11E-05
1368952_at 1.38 0.00285
Gamma-aminobutyric acid (GABA) A receptor, epsilon GABRE 1388049_at 1.84 3.19E-05
Gamma-aminobutyric acid (GABA) A receptor,
gamma 1
GABRG1 1387706_at 1.25 0.0300
Gamma-aminobutyric acid (GABA) receptor, theta GABRQ 1387706_at 1.25 0.0300
Gamma-aminobutyric acid (GABA) B receptor, 2 GABBR2 1370701_at 1.63 0.0279
All GABA and glutamate receptor subunits differentially expressed in human oculomotor and spinal motor neurones are included in the table,
and data from rat and mouse oculomotor nucleus versus spinal cord shown, where significant differential expression was found
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susceptible, and oculomotor neurons, which are resistant to
the degenerative process in ALS. Nearly 2,000 genes are
significantly differentially expressed by the two motor
neuron subtypes, with a conservative false discovery rate
of 0.001. This is the first study of differences in the
gene expression characteristics between ALS-resistant and
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ALS-vulnerable motor neuron subtypes in human tissue. A
recent paper by Hedlund et al. [14] used microarray anal-
ysis of motor neurons of normal mice, to compare the
transcriptional profiles of OM, hypoglossal and cervical
spinal motor neurons. They also found differential
expression between genes in the functional categories of
mitochondrial function, ubiquitination, cell adhesion and
RNA metabolism. Upregulation of Hox genes was seen in
cervical spinal motor neurons and hypoglossal neurons,
compared to oculomotor neurons. However, three genes
highlighted in the study, IGF-1 and guanine deaminase
(upregulated in oculomotor neurons), and peripherin
(upregulated in spinal motor neurons), showed no differ-
ential expression in our study of human motor neurons,
which may reflect species-specific differences in expres-
sion between the motor neuron subtypes.
Functional categories of genes differentially expressed
between oculomotor and spinal motor neurons
Using Gene Ontology enrichment analysis, we have shown
that motor neuron subtypes with different susceptibility to
degeneration in ALS show differential expression of genes
with a function in synaptic transmission, ubiquitin-depen-
dent proteolysis, mitochondrial function, transcriptional
regulation, immune system functions and the extracellular
matrix. These differences may reflect their diverse
embryological origin, the different milieu in the brainstem,
or differences in the structure and function of oculomotor
units compared to motor units of other skeletal muscles.
For example, upregulation of genes with mitochondrial
functions, including the respiratory chain complex, is likely
to reflect the high metabolic demand placed on oculomotor
neurons, due to their high firing rate. Hox genes are key
controllers of rostro-caudal patterning, and of motor neuron
pools within each level of the hindbrain and spinal cord [3,
4, 11]. The patterns of differential expression of Hox genes
and of engrailed 1 and 2 therefore reflect the positions of
these neurons on the rostro-caudal axis. The functional
implications of differential expression of collagen subunits
between OM and LSC motor neurons are unknown, but are
intriguing in the light of findings of altered composition of
the extracellular matrix in patients with ALS, and the
clinical observation that they are resistant to bedsores [24,
42, 43].
Amongst the differences in gene expression observed,
are transcriptional characteristics that render oculomotor
neurons resistant to the degenerative process in ALS. For
example, there is evidence that the capacity of the pro-
teasome system to degrade proteins may be a limiting
factor in the vulnerability of neurons to the degenerative
process [19]. Our observation of an increase in the
expression of genes encoding components of the ubiquitin–
proteasome system in OM neurons compared to LSC motor
neurons is a novel finding, which may contribute to their
relative resistance to degeneration. We have made this
array data freely available to the scientific community
(http://www.ncbi.nlm.nih.gov/geo/; GSE 40438) to explore
other gene expression changes which may lead to a func-
tional difference between OM and LSC motor neurons.
We used datasets from two different species, obtained
from the GEO Omnibus repository, to confirm the differ-
ential gene expression seen on microarray analysis in
human OM and LSC motor neurons. There was marked
concordance in the functional categories of genes differ-
entially expressed between the three species analysed, with
the most significant enrichment occurring in all three spe-
cies, in genes with a function in synaptic transmission.
GABA and glutamate receptor subunits differentially
expressed between the motor neuron subtypes in human
tissue showed concordant changes in mouse and/or rat
tissue in the majority of cases.
Relative resistance of oculomotor neurons
to excitotoxicity
There is substantial evidence that excitotoxicity plays a
role in the motor neuronal death of ALS, and that motor
neurons are selectively vulnerable to excitotoxic cell
injury. Motor neurons possess atypical AMPA receptors
that express proportionately fewer GluR2 receptor sub-
units, relative to other GluR subunits [22, 53]. This low
expression of GluR2 would render them more permeable to
Fig. 4 a and b Concentration–response relation for AMPA-induced
whole-cell currents in lumbar spinal cord and oculomotor neurons.
Currents were recorded in 20 mM extracellular Na? at -60 mV, in
response to AMPA concentrations ranging from 5 lM to 5 mM.
a Representative current traces elicited by AMPA. b Each point
represents mean ± SEM from three cells (*P \ 0.05, **P \ 0.01,
Student’s t test). EC50 values estimated from fits to pooled data were
118.6 lM for lumbar spinal cord motor neurons and 123.2 lM for
oculomotor neurons. c Whole-cell currents recorded in Na?-free
extracellular solution containing 50 mM Ca2? at -60 mV in lumbar
spinal cord and oculomotor neurons, evoked by AMPA 100 lM
(n = 6). Columns represent the peak amplitudes of agonist-induced
whole-cell currents (mean ± SEM, **P \ 0.001, P \ 0.05, Student’s
t test). d and e Concentration–response relation for kainate-induced
whole-cell currents in lumbar spinal cord and oculomotor neurons.
Currents were recorded in 20 mM extracellular Na? at -60 mV, in
response to kainate concentrations ranging from 50 lM to 50 mM.
d Representative current traces elicited by kainate. e Each point
represents mean ± SEM from three cells (*P \ 0.05, **P \ 0.01,
Student’s t test). EC50 values estimated from fits to pooled data were
1.12 mM for lumbar spinal cord motor neurons and 1.26 mM for
oculomotor motor neurons, respectively. f Whole-cell currents
recorded in Na?-free extracellular solution containing 50 mM Ca2?
at -60 mV in lumbar spinal cord and oculomotor neurons, evoked by
kainate 1 mM (n = 6). Columns represent the peak amplitudes of
agonist-induced whole-cell currents (mean ± SEM, **P \ 0.001,
P \ 0.05, Student’s t test)
b
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calcium, and thus more vulnerable to excitotoxic injury.
Spinal motor neurons show a higher AMPA receptor cur-
rent density than ALS-resistant dorsal horn neurons [57].
SOD1G93A transgenic mice crossed with ChAT-GluR2
mice that overexpress the GluR2 subunit in cholinergic
neurons have reduced calcium permeability of the motor
neuronal AMPA receptors, and show prolonged survival
compared to the single heterozygote SOD1G93A mice [54].
GluR2 pre-mRNA is edited by the enzyme ADAR2
(adenosine deaminase acting on RNA2), to convert aden-
osine to inosine at the Q/R site. Failure of this editing
function has been described in motor neurons of patients
with sporadic ALS [21]. Furthermore, conditional knock-
down of ADAR2 in motor neurons of mice [15], or
expression of a functionally modified GluR2 subunit with
increased calcium permeability [25] causes a slow decline in
motor neurons of the spinal cord and brainstem. In ADAR2
knockout mice, this motor neuron degeneration spares the
oculomotor nucleus, suggesting that excitotoxicity is an
important determinant of the selective vulnerability of
spinal motor neurons, a finding that is further supported by
the present study.
We observed upregulation in OM neurons relative to
LSC motor neurons of several GABA and glutamate
receptor subunits. A previous study showed no difference
between ALS-resistant and -vulnerable brainstem motor
nuclei in the expression of mRNA or protein of GluR2 and
GluR4 [26]. However, we found that OM neurons express
higher levels of GluR2, which may render them less sus-
ceptible to excitotoxic injury. Although the proportional
expression of GluR2 relative to other GluR receptor sub-
units was not determined in this study, our functional data
confirm that the expression changes observed lead to a
higher level of calcium influx in response to AMPA/kai-
nate in spinal motor neurons than in oculomotor neurons.
The higher level of expression of GABA receptor sub-
units in OM neurons may reflect increased expression of
GABA receptors, which may be neuroprotective through
Fig. 5 a and b Concentration–response relation for GABA-induced
whole-cell currents in lumbar spinal cord and oculomotor motor
neurons. Currents were recorded at -60 mV, in response to GABA
concentrations ranging from 0.1 mM to 100 mM. Each point
represents mean ± SEM from three cells (*P \ 0.05, Student’s
t test). EC50 values estimated from fits to pooled data were 6.1 mM
for lumbar spinal cord motor neurons and 5.7 mM for oculomotor
motor neurons, respectively. c GABA-induced whole-cell currents in
lumbar spinal cord and oculomotor neurons. Whole-cell currents
evoked by 6 mM GABA were recorded at -60 mV. Columns
represent the peak amplitudes of GABA-induced whole-cell currents
(mean ± SEM, *P \ 0.05, n = 6, Student’s t test)
106 Acta Neuropathol (2013) 125:95–109
123
increasing GABA transmission to protect against excessive
neuronal excitability. Alternatively, the upregulation of
some GABA receptor subunits in OM neurons may reflect
alteration in subunit composition, which is thought to
determine functional diversity of the receptor [28]. This
finding is supported by an earlier study showing lower
expression of GABAR subunits in vulnerable than resistant
motor neurons in brainstem motor nuclei of normal rats
[31].
We carried out patch clamp recording of AMPA and
GABA-induced whole-cell currents in OM and LSC motor
neurons from rat, in order to determine the functional effect
of the observed differences in expression of AMPA and
GABA receptor subunits. Amplitudes of whole-cell cur-
rents evoked by AMPA receptor agonists were
dramatically larger in LSC motor neurons than OM neu-
rons. This difference in AMPA receptor current between
the two types of motor neuron, observed with both AMPA
and kainate as agonists, was detected over the full range of
the agonist concentration–response curves. These whole-
cell currents were generated by inward influx of calcium
ions, through AMPA receptor activation, as they were
observed in extracellular solutions free of Na?, and in the
presence of MK-801 to block NMDA receptors, tetrodo-
toxin to block voltage-gated Na? channels and Cd2? to
block voltage-gated Ca2? channels. The higher amplitude
of the receptor-mediated current in LSC motor neurons
could be explained by a higher density of AMPA receptors,
but this is not supported by the microarray data, which
showed reduced expression of AMPA receptor subunits in
LSC motor neurons. Alternatively, the differential expres-
sion of GluR1 and GluR2 subunits may reflect an alteration
in subunit composition, which could result in an increase in
single-channel conductance or in open probability of cal-
cium channels. A relatively higher somatic size in spinal
motor neurons could also result in higher amplitude of the
receptor-mediated current, but this is unlikely to explain
the differences observed, as the GABAA-induced current
was decreased in LSC motor neurons relative to OM
neurons. Amplitudes of GABAA receptor-mediated inward
chloride currents were significantly higher in OM neurons
than in LSC motor neurons. This higher amplitude could be
explained by a higher expression of GABA receptors in
OM neurons, reflected by the observed increase in
GABRA1, B1 and B2 receptor subunit expression, or by
altered subunit composition of the receptors, resulting in a
change in the physiological channel properties.
The difference in AMPA and GABA-mediated inward
currents, with an increase in AMPA-mediated inward cal-
cium current, and decrease in GABA-mediated inward
current in LSC motor neurons, relative to OM neurons,
would be predicted to increase the susceptibility of spinal
motor neurons to excitotoxicity. Interest in excitotoxicity
in ALS has largely focussed on the role of excess glutamate
activity; however, insufficient synaptic inhibition may also
play an important role. Spinal motor neurons and oculo-
motor neurons are innervated by GABAergic inhibitory
neurons [35, 51], which generate fast inhibitory potentials
to regulate the amplitude and duration of excitatory post-
synaptic potentials. GABAergic transmission has been
shown to be neuroprotective in motor neuron cultures
exposed to glutamate [58], and in other experimental par-
adigms where excitotoxicity contributes to neuronal death
[34]. Loss of cortical inhibitory signals [8], and depletion
of cortical GABAergic interneurons [37] have been dem-
onstrated in patients with ALS. PET studies have also
shown reduction in binding of the GABAA receptor ligand,
flumazenil, in the extramotor cortex of ALS patients, cor-
relating with the extent of cognitive dysfunction [30].
Furthermore, patients with rapidly progressive disease
were shown to have loss of cortical inhibitory GABAergic
mechanisms, compared to those with a more slowly pro-
gressive ALS variant [56]. There has been increasing
interest recently in the potential role of degeneration of
inhibitory interneurons in the pathogenesis of ALS.
Reduced expression of GABAergic and glycinergic mark-
ers has been demonstrated in the ventral horns, and reduced
glycine-mediated currents in cultured motor neurons from
mutant SOD1 mice [2, 16]. The present study contributes
to a growing body of evidence that a reduction in GABA-
mediated synaptic transmission plays a role in the patho-
genesis of selective degeneration of spinal motor neurons
in ALS.
Conclusion
We have used genome-wide transcriptome analysis to
determine systematically the differences between two
populations of motor neurons that show differential sus-
ceptibility to degeneration in ALS. The transcriptional
profiles of oculomotor and spinal motor neurons are dis-
tinct, with differences in nearly 2,000 genes, at a
conservative false discovery rate. Significant differences
might be expected due to the different embryological ori-
gin, location, and structure and function of oculomotor
units. However, amongst the changes observed are those
that determine the disease-resistant properties of oculo-
motor neurons. Analysis of the transcriptional profiles of
oculomotor nucleus and spinal cord tissue of two further
species showed that differential expression of genes with a
function in synaptic transmission, including GABA and
glutamate receptor subunits, is conserved across the three
species. We carried out functional studies, using patch
clamp recording to measure whole-cell currents induced by
AMPA and GABA receptor agonists, and found significant
Acta Neuropathol (2013) 125:95–109 107
123
upregulation of AMPA-induced calcium currents, and
downregulation of GABA-induced chloride currents in the
disease-susceptible spinal motor neurons. These micro-
array and electrophysiology data provide strong evidence
that reduced susceptibility to excitotoxicity, mediated in
part through increased GABAergic transmission, is an
important determinant of the relative resistance of oculo-
motor neurons to degeneration in ALS.
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